Gates Foundation, the Microsoft founder has in recent years emerged as one of the largest benefactors for global health issues (Curr. Biol. (2003) 13, R820).
With such pressing matters at hand and potential future problems, such as the avian flu strains from Asia, emerging rapidly, it might appear strange that the global organisation should have dedicated a significant part of its conference time to a disease which has not infected anybody in more than a quarter of a century. But then, smallpox isn't just any old disease. While its eradication at the end of the 1970s is undeniably the WHO's greatest triumph, smallpox is also one of the most infectious deadly diseases in humans and one of the oldest bioweapons, as its use against Native Americans has been recorded in 1760. The greatest contrast with UK triumphalism was to be found in The Independent, in which science editor Steve Connor authored a major news-feature titled 'First stem cells taken from cloned embryos', complete with an excellent graphic representation of the process developed in Seoul. This was accompanied by a much briefer report under a different byline on the Newcastle work. The Independent reminded readers that the Seoul National University team reported the world's first cloned human embryo last year, and that the UK research was 'a long way behind the Korean development'. The newspaper also published an editorial ('There is no reason to fear this brave new world of hope') that did not even mention the UK research.
The Financial Times gave the headline 'Asian scientists unveil breakthrough in stem cell cloning from sick patients' to its news
